EUVIMEDEUVIMED entdecken
Crossref

Exosome‐derived miR ‐182‐5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK / SEMA5a / PI3K pathway

Jifei Wang, Wangjie Jiang, Shuochen Liu, Kuangheng Shi, Yaodong Zhang, Yananlan Chen, Jijun Shan, Yuming Wang, Xiao Xu, Changxian Li iD, Xiangcheng Li iD

Liver International · 2024-02 · 44 (2) · 370-388

DOI: 10.1111/liv.15773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 10.11.2023. Verfasst von Jifei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Exosomes, MicroRNAs, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: The Key Research and Development Program of Jiangsu Province, The National Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Increasing evidence suggested that miRNAs regulated the expression of pivotal genes involved in oncogenesis and malignant phenotype. In this project, the purpose was to make an inquiry to the effect and mechanism of miR‐182‐5p in the progression of cholangiocarcinoma.

Methods

By analysing TCGA and GEO databases, combined with tissue expression levels, miR‐182‐5p was identified as one of the most valuable miRNAs for research. The function and relationships between miR‐182‐5p and downstream target genes were both verified by in vitro and in vivo experiments. Methylation‐specific PCR and bisulphite sequencing were used to detect the methylation level changes of downstream gene promoter.

Results

We found that miR‐182‐5p could be taken up by exosomes secreted from cholangiocarcinoma. Moreover, exosomal derived miR‐182‐5p promoted vascular endothelial cell proliferation and migration and induced angiogenesis by targeting ADK/SEMA5a. Subsequently, the PI3K/AKT/mTOR signalling pathway was activated and ultimately caused resistance to gemcitabine and cisplatin.

Conclusions

Our findings suggested that the miR‐182‐5p/ADK/SEMA5a axis might serve as a potential therapeutic target for cholangiocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMicroRNAsCholangiocarcinomaBile Duct NeoplasmsHumansPhosphatidylinositol 3-KinasesCell ProliferationBile Ducts, Intrahepatic

Stichwörter der Autor:innen

angiogenesischolangiocarcinomaexosomesmiR-182-5p

Substanzen

Phosphatidylinositol 3-KinasesMicroRNAsMirn182 microRNA, human

Autor:innen und Institutionen

  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China.
  • NHC Key Laboratory of Living Donor Liver Transplantation, Nanjing Medical University, Nanjing, Jiangsu, China.

ORCID-Profile: Changxian Li, Xiangcheng Li

Förderung

  • The Key Research and Development Program of Jiangsu Province
  • The National Natural Science Foundation Project

Zitieren

APA

Wang, J., Jiang, W., Liu, S., Shi, K., Zhang, Y., Chen, Y., Shan, J., Wang, Y., Xu, X., Li, C., & Li, X. (2024). Exosome‐derived miR ‐182‐5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK / SEMA5a / PI3K pathway. Liver International, 44(2), 370-388. https://doi.org/10.1111/liv.15773

Vancouver

Wang J, Jiang W, Liu S, Shi K, Zhang Y, Chen Y, et al. Exosome‐derived miR ‐182‐5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK / SEMA5a / PI3K pathway. Liver International. 2024;44(2):370-388. doi:10.1111/liv.15773

BibTeX
@article{Wang2024,
  author = {Wang, Jifei and Jiang, Wangjie and Liu, Shuochen and Shi, Kuangheng and Zhang, Yaodong and Chen, Yananlan and Shan, Jijun and Wang, Yuming and Xu, Xiao and Li, Changxian and Li, Xiangcheng},
  title = {Exosome‐derived miR ‐182‐5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK / SEMA5a / PI3K pathway},
  journal = {Liver International},
  year = {2024},
  volume = {44},
  number = {2},
  pages = {370--388},
  doi = {10.1111/liv.15773}
}
Kostenlos starten →